Asia-Pacific is an important growth region for the IgA nephropathy treatment market as kidney-disease awareness, diagnostic capabilities, nephrology services, and healthcare investment continue to expand. The region accounted for about 20% of global market share in the report’s analysis.marketresearchfuture Countries such as China and Japan are important regional markets because of their...